Strides Pharma Science Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 661.29 | 660.52 | 609.71 |
| Operating Expense | 588.49 | 521.53 | 531.34 |
| Net Profit | 9.26 | 72.93 | 16.35 |
| Net Profit Margin | 1.40% | 11.04% | 2.68% |
| Earning Per Share | 1 | 7.91 | 1.77 |
| EBIDTA | 69.92 | 141.94 | 73.83 |
| Effective Tax Rate | 6.99% | 10.63% | 7.18% |
Particulars
Sep 2026
Revenue661.29
Operating Expense588.49
Net Profit9.26
Net Profit Margin1.40
Earning Per Share1
EBIDTA69.92
Effective Tax Rate6.99
